Home > Compound List > Product Information
Propranolol_Molecular_structure_CAS_525-66-6)
Click picture or here to close

Propranolol

Catalog No. Bio-0732 Name InterBioScreen
CAS Number 525-66-6 Website http://www.ibscreen.com
M. F. C16H21NO2 Telephone +7 49652 40091
M. W. 259.34344 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 453

SYNONYMS

IUPAC name
[2-hydroxy-3-(naphthalen-1-yloxy)propyl](propan-2-yl)amine
IUPAC Traditional name
[2-hydroxy-3-(naphthalen-1-yloxy)propyl](propan-2-yl)amine
Synonyms
1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol

DATABASE IDS

CAS Number 525-66-6

PROPERTIES

Application(s) Antiarrhythmic agent
Application(s) Hypotensives
Application(s) Local anesthetic
Mechanism of Action Beta-Adrenergic blocking agent
Mechanism of Action It is a non-selective beta blocker, that is, it blocks the action of epinephrine on both beta1- and beta2-adrenergic receptors.
Mechanism of Action It has little intrinsic sympathomimetic activity (ISA) but has strong membrane stabilizing activity (only at high blood concentrations, eg overdosage).
Mechanism of Action Only L-propranolol is a powerful adrenoceptor antagonist, whereas D-propranolol is not

DETAILS

REFERENCES

  • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 2, 633C; 634A, (nmr)
  • Howe, R. et al., Nature (London), 1965, 207, 594; 1966, 210, 1336, (synth, resoln)
  • U.K. Pat., 1965, 994 918; CA, 63, 8130d, (synth)
  • Dukes, M. et al., J. Med. Chem., 1971, 14, 326
  • Barrans, Y. et al., Acta Cryst. B, 1973, 29, 1264, (cryst struct)
  • Paul, R. et al., J.O.C., 1975, 40, 1653, (abs config)
  • Routledge, P.A. et al., Appl. Pharmacokinet., 1980, 464, (rev, metab, pharmacol)
  • Fitzgerald, J.D., Pharmacol. Antihypertens. Drugs, 1980, 195, (rev, pharmacol)
  • Tsuda, Y. et al., Chem. Pharm. Bull., 1981, 29, 3593, (synth, deriv)
  • Imuchijima, S. et al., Agric. Biol. Chem., 1982, 46, 1153, (metab, synth)
  • Thompson, J.A. et al., J. Chromatogr., 1982, 238, 470, (synth, sepn)
  • Mishriki, A. et al., Pharmacotherapy (Carlisle, Mass.), 1983, 3, 334-341, (rev)
  • Katsuki, T., Tet. Lett., 1984, 25, 2821, (synth)
  • Alkondon, M. et al., Can. J. Physiol. Pharmacol., 1986, 64, 1455, (rev, pharmacol)
  • Okamoto, Y. et al., Chem. Lett., 1986, 7, 1237, (resoln)
  • Klunder, J.M. et al., J.O.C., 1986, 51, 3710, (synth)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 4064
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 638
  • Sakuraba, S. et al., Chem. Pharm. Bull., 1995, 43, 738, (synth)
  • Abe, Y. et al., Chem. Pharm. Bull., 1996, 44, 1521, (resoln)
  • Matchett, M.W. et al., Chirality, 1996, 8, 126-130, (resoln)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, ICB000; ICC000; PNB790; PNB800